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Human exposure to Bartonella clarridgeiae has been reported only on the basis of antibody detection. We report for the first
time an asymptomatic human blood donor infected with B. clarridgeiae, as documented by enrichment blood culture, PCR, and
DNA sequencing.
CASE REPORT
During a study designed to determine the prevalence of Barto-nella bacteremia in samples from 500 blood donors from
the Blood Bank of State University of Campinas (UNICAMP—
HEMOCENTRO), Sao Paulo State, Brazil (L. H. U. Pitassi, P. P. V.
de Paiva Diniz, D. G. Scorpio, M. R. Drummond, B. G. Lania,
M. L. Barjas-Castro, S. Colombo, S. Sowy, E. B. Breithschwerdt,
W. L. Nicholson, and P. E. N. F. Velho, submitted for publica-
tion), we identified a blood donor infected with Bartonella clar-
ridgeiae on the basis of specific PCR amplification and DNA
sequencing of an amplicon obtained from the 14-day liquid en-
richment blood culture.
The donor was a 39-year-old male from Santo Antonio de
Posse (22°36=22S, 46°55=10W), a city with approximately 20,000
inhabitants located 88 miles north of Sao Paulo City, the capital of
Sao Paulo state, southeastern Brazil. The man self-reported donat-
ing blood from 6 to 10 times previously. For more than 10 years,
the man shared his home with a cat, and he had sustained a bite 2
years earlier. At that time, he had no symptoms. In addition, the
man had domiciliary contact with two pet dogs for 4 years. He
reported that these animals occasionally had flea and tick infesta-
tion. He had no tattoos and had never traveled outside Sao Paulo
state, Brazil.
Immediately after the collection of a blood unit, 5 ml of blood
was collected into an EDTA tube, with other 5 ml collected into a
serum separator tube via accessory port. After serum centrifuga-
tion, samples were stored at 20°C until analysis. Two milliliters
of the donor’s whole EDTA blood was thawed and added into 8 ml
of liquid Bartonella Alpha-Proteobacteria Growth (BAPGM) me-
dium (1), and the reaction mixture was incubated at 37°C in 5%
CO2, in a water-saturated atmosphere. The flask was maintained
with a constant shaking motion for 14 days. A negative-control
flask containing only BAPGM medium was added to each batch of
samples tested and subjected to the same laboratory procedures
and culture conditions. After a 14-day incubation period, a 1-ml
aliquot of liquid culture medium was used for DNA extraction
and another 1-ml aliquot was plated onto a blood agar plate and
incubated for an additional 42 days. Blood agar plates were pre-
pared with 30% of sheep blood confirmed to be free of Bartonella
DNA by PCR (2). The liquid culture negative-control blood-agar
plate was incubated under the same conditions. All culture meth-
ods were carried out in a class 2 biosafety cabinet in order to
minimize the risk of specimen DNA or bacterial contamination
and to protect laboratory personnel.
The liquid culture sample used for molecular analysis was cen-
trifuged, and the pellet was tested for the presence of Bartonella
DNA. Genomic DNA from the liquid culture was extracted using
a QIAamp DNA minikit (Qiagen Inc., Valencia, CA, USA) follow-
ing the manufacturer’s instructions and tested by a real-time PCR
using primers manually designed to amplify a fragment of the
16S-23S rRNA intergenic transcribed spacer (ITS) region of all
Bartonella species. The 25-l reaction mixture contained 1 PCR
mix (SYBR Premix Ex Taq; TaKaRa Bio Inc., Shiga, Japan), 7.5
pmol of primer 314A-s (5=-CGTTTCTCTTTCTTCMGATGATG
ATCCC-3=), 7.5 pmol of primer 314B-s (5=-CGTTTCTCTTTCT
TCRGATGATGATCCC-3=), 10.5 pmol of primer 382-as (5=-AC
TTSAACCTCCGACCTCACGCTTAT-3=), 1 ROX reference
dye, and 5 l of DNA template. Amplifications were performed
under the following conditions: one hot-start cycle at 95°C for 1
min followed by 50 cycles of denaturing at 94°C for 10 s, annealing
at 58°C for 20 s, and extension at 72°C for 20 s. Amplification was
detected by SYBR green I fluorescence with emission at 522 nm.
The expected melting curves were obtained. Serial dilutions of B.
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henselae DNA from 109 genome equivalents (GE) per microliter to
1 GE/l were used as a positive control, for the determination of
the limit of detection of this assay (5 copies per reaction). A Mas-
termix reagent negative control was included in each batch of
samples tested. The amplicons generated were purified (Mini-
Elute kit; Qiagen, Valencia, CA, USA) according to the manufac-
turer’s instructions and sequenced with a fluorescence-based
automated sequencing system (Eurofins MWG Operon, Hunts-
ville, AL, USA). Chromatogram evaluation, primer deletion, and
sequence alignment were performed using Contig Express soft-
ware and AlignX software (Vector NTI Suite 10.1; Invitrogen
Corp., Carlsbad, CA, USA). The bacterial species was defined by
comparing similarities with other sequences deposited in the
GenBank database using the Basic Local Alignment Search Tool
(3). A phylogenetic tree (Fig. 1) was generated based on 136-bp
sequences of the ITS of B. clarridgeiae from the blood donor and
closely related organisms by using the maximum-likelihood
method on the basis of the Kimura 2-parameter model, with boot-
strap support based on 1,000 replicates (Molecular Evolutionary
Genetics Analysis [MEGA] software, version 5.2).
The donor serum sample was analyzed for the presence of IgG
antibodies to B. henselae and B. quintana antigens grown in Vero
cell cultures by an indirect immunofluorescence assay (IFA) ac-
cording to a previously described procedure (4). The bacterial
antigens were supplied by the Centers for Disease Control and
Prevention (CDC, Atlanta, GA, USA). The serum sample was di-
luted 1/64 in phosphate-buffered saline (PBS), and 25 l was ap-
plied to Bartonella-infected cells fixed to a glass slide and incu-
bated for 30 min at 37°C. The slides were washed three times (for
5 min each time) in PBS, overlaid with fluorescein isothiocyanate-
conjugated goat anti-human immunoglobulin IgG (Sigma, St.
Louis, MO, USA) at a dilution of 1/150, incubated at 37°C for 30
min, washed, and dried. Slides were examined on a Labophot
fluorescence microscope (Nikon, Melville, NY, USA). The cutoff
titer of the IFA was 1/64. Endpoint titers were not determined. A
positive test was warranted if brightly stained bacteria could be
detected by fluorescence microscopy at400 magnification. Pre-
viously IFA-negative serum samples were used as negative con-
trols.
By real-time PCR, amplicons of 190 bp in size were obtained
from the liquid culture aliquot. After primer deletion, the remain-
ing 136-bp sequence was 100% similar to B. clarridgeiae DNA
sequences from samples collected from cats in the United States
and Brazil (Fig. 1). Following subculture, no isolate was obtained
from this subject and he was not seroreactive to B. henselae and B.
quintana antigens.
This report describes the molecular documentation of B. clar-
ridgeiae DNA in human blood. The subject was an asymptomatic
blood donor who had previously donated blood multiple times.
Bartonella spp. are the only known Gram-negative bacilli that can
live inside erythrocytes while often causing persistent infections in
the host (5). To date, 15 species, subspecies, or Candidatus species
of Bartonella have been known to infect humans (Table 1).
Asymptomatic infection with Bartonella bacilliformis in humans is
well established (6), and numerous outwardly healthy animals
support persistent Bartonella sp. bacteremia (5). However, a spec-
trum of disease manifestations associated with Bartonella spp. has
gained importance within the last decades. The genus Bartonella
comprises a group of reemerging and neglected zoonotic patho-
gens that have been associated with a broad range of serious hu-
man diseases (Table 1).
Worldwide, Bartonella henselae is a causative agent of cat
scratch disease (CSD), bacillary angiomatosis, peliosis hepatis,
bacteremia, endocarditis, chronic lymphadenopathy, and neuro-
logical disorders (7–9). B. clarridgeiae has also been suggested to
cause fever, headaches, malaise, lymphadenopathy (10, 11), and
thoracopulmonary manifestations (12) in humans; endocarditis
(13) and hepatic diseases (14) in dogs; and blindness (15) and
neuritis (16) in cats. The diversity of the clinical manifestations
FIG 1 Phylogenetic tree based on 136 bp from the 16S-23S rRNA intergenic transcribed spacer (ITS) sequences of Bartonella clarridgeiae obtained from a blood
donor (in boldface) and closely related organisms constructed by using the maximum-likelihood method on the basis of the Kimura 2-parameter model. Each
bacterial name is followed by isolation source and geographic-origin data, and the GenBank accession number is provided in parentheses. The numbers at the
nodes indicate percentages of bootstrap support based on 1,000 replicates. Percentages corresponding to partitions reproduced in fewer than 50% of bootstrap
replicates are collapsed. The scale bar indicates 0.05 substitutions per nucleotide position.
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associated with bartonellosis depends mainly on the virulence of
the Bartonella sp. or strain, the level of evolutionary host adapta-
tion of the bacterium, and the immune response of the host, which
is a critical determinant of disease expression (5). In some pa-
tients, and especially in immunocompromised subjects, the dis-
ease can be fatal (17). The long-term consequence of chronic sub-
clinical infection with Bartonella spp. in immunocompetent
humans is currently unknown.
Previously, serological evidence of anti-B. clarridgeiae antibod-
ies supported hypotheses of exposure in humans (10, 12). How-
ever, to our knowledge, B. clarridgeiae was never isolated or doc-
umented by molecular techniques in blood or tissue samples from
a human. B. clarridgeiae DNA was detected from fleas (18), and
bacteremic infection has been reported in sick dogs (13, 14) and in
the healthy pet cat of a sick veterinarian with CSD (11). Experi-
mentally, B. clarridgeiae can be transmitted by blood transfusion
and be detected by PCR from blood, brain, lymph node, myocar-
dium, liver, and kidney tissues not only from blood culture-posi-
tive cats but also from blood culture-negative cats (19). Further-
more, natural concomitant infection with B. clarridgeiae and B.
henselae has been reported in domestic cats (20), because both
Bartonella spp. are considered adapted to this host and are likely
transmitted by the common cat flea (Ctenocephalides felis). In
vitro, both of these Bartonella species can infect feline erythrocytes
(21) and are capable of entering human endothelial cells (22).
The DNA fragment of B. clarridgeiae sequenced from this
blood donor was 100% similar to DNA sequences obtained from
samples collected from cats in Brazil (23) and from a cat from the
United States (24). Cats are considered the natural reservoir of B.
clarridgeiae, being capable of sustaining high levels of bacteremia
(25). The blood donor infected with B. clarridgeiae reported long-
term daily contact with two dogs and a cat for years, and he re-
ported a cat bite 2 years earlier. Despite the fact that these animals
were not tested for Bartonella sp. bacteremia, the fleas and ticks
that occasionally infested his cat and dogs may have transmitted
the pathogen to the owner. In a previous study of 14 immunocom-
petent people infected with Bartonella henselae or B. vinsonii
subsp. berkhoffii, all participants reported frequent exposure to
fleas and ticks from domestic cats and dogs (26).
Annually, about 15 million units of red cells are transfused in
the United States and about 85 million worldwide (27). The over-
all rate of any bacterial contamination of red blood cells (RBCs) in
blood units reportedly ranges from 0.03% to 0.3% (28). Bacterial
contamination is the third most common cause of death from
transfusion in the United States (29). Bartonella transmission by
blood transfusion has not yet been described; however, in light of
our findings, this possibility should be considered. We previously
described the presence of B. henselae in a RBC unit from an
asymptomatic donor (30) and noted that B. henselae is also able to
survive in stored red blood cell units for 35 days (31). Addition-
ally, suspected iatrogenic transmission by needle pricking of B.
vinsonii subsp. berkhoffii and B. henselae to two veterinarians who
subsequently developed different clinical manifestations (32, 33)
further supports the hypothesis that Bartonella transmission by
blood transfusion or blood products is feasible.
Our findings demonstrate that B. clarridgeiae can be present in
healthy blood donors, and may pose a risk to blood recipients, in
particular immunocompromised patients receiving blood trans-
fusions. The relevance of the genus Bartonella to transfusion med-
icine in Brazil and other countries should be further investigated.
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B. bacilliformis Oroya fever, verruga peruana 6
B. quintana Bacillary angiomatosis, trench fever, bacteremia 34
B. henselae Cat scratch disease, endocarditis, bacillary angiomatosis, peliosis hepatis, bacteremia 7–9
B. elizabethae Fever, endocarditis 35
B. grahamii Cat scratch disease (lymphadenopathy, reddish papule, abscess) 36
B. vinsonii subsp. berkhoffii Endocarditis, arthritis, neurological disease, and epithelioid hemangioendothelioma 33
B. koehlerae Anxiety, severe headaches, muscle spasms, decreased peripheral vision, and hallucinations 37
B. alsatica Fever, lymphadenitis, and endocarditis 38
B. vinsonii subsp. arupensis Fatigue, headache, and myalgias 39
B. washoensis Meningitis 40
B. rochalimae Bacteremia, fever, and splenomegaly 24
B. tamiae Fever, headache, myalgia, maculopapular rash, petechial rash in arms and legs,
abnormalities in liver function
41
B. melophagia Dry cough, fatigue, muscle pain, and severe chills 42
B. mayotimonensisa Endocarditis 43
B. volans (including volans-like) Symptoms uncertain 44
B. clarridgeiae Asymptomatic This report
a Candidate species in the genus Bartonella.
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